To Better Understand COVID-19, Researchers Review Aging, Immune Response to Viral Infections

Michigan Medicine - University of Michigan

Newswise — Information about the new COVID-19 infection is constantly evolving based on what clinicians see firsthand. One constant, so far, is that the older population tends to fare worse than younger folks with this disease.

A team led by Daniel Goldstein, M.D., already studies aging and the influenza viral infection, and took this spring away from their lab to figure out if any of their other research, and other research they regularly read, could be helpful in the fight against COVID-19.

“Influenza is of course a different pathogen, but it may give some catalyst for research with the current SARS-CoV2 infection,” says Goldstein, of the Michigan Medicine Frankel Cardiovascular Center. Goldstein, with Judy Chen, a doctoral student, and William Kelley, a postdoctoral research fellow, published a new review in the Journal of Immunology.

“We believe some of the phenomena that we’re seeing with the current pandemic are similar to what we’ve seen in our research with aging,” Goldstein says. “There seems to be a higher mortality because of dysregulated inflammation more than impaired viral control.”

Additionally, increasing activation of neutrophils is reported in the current COVID-19 pandemic, which the authors have reported in their flu models. And how aging affects the immune system prior to infection is the same, and also potentially applicable in understanding the population afflicted by COVID-19, the authors say.

“However, there are certainly some unique things about this virus we’re still learning,” Goldstein says.

SEE ORIGINAL STUDY




Filters close

Showing results

1120 of 5636
Newswise:Video Embedded australia-accelerates-new-covid-19-vaccine-to-fight-mutant-strains
VIDEO
Released: 13-May-2021 2:05 AM EDT
Australia accelerates new COVID-19 vaccine to fight mutant strains
University of South Australia

A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus.

Released: 12-May-2021 5:10 PM EDT
Understanding SARS-COV-2 proteins is key to improve therapeutic options for COVID-19
Bentham Science Publishers

COVID-19 has had a significant impact since the pandemic was declared by WHO in 2020, with over 3 million deaths and counting, Researchers and medical teams have been hard at work at developing strategies to control the spread of the infection, caused by SARS-COV-2 virus and treat affected patients.

Newswise: 264700_web.jpg
Released: 12-May-2021 4:55 PM EDT
COVID-19 vaccine does not damage the placenta in pregnancy
Northwestern University

A new Northwestern Medicine study of placentas from patients who received the COVID-19 vaccine during pregnancy found no evidence of injury, adding to the growing literature that COVID-19 vaccines are safe in pregnancy.

Newswise: For the first time, Argonne researchers reveal how COVID-19 has transformed communities
Released: 12-May-2021 4:05 PM EDT
For the first time, Argonne researchers reveal how COVID-19 has transformed communities
Argonne National Laboratory

Argonne researchers have launched new map-based tools that show how communities held up as COVID-19 spread.

Released: 12-May-2021 3:45 PM EDT
Parks not only safe, but essential during the pandemic
Drexel University

Parks played an important role for people seeking respite from the toll of social isolation during the pandemic, and according to new research from Drexel University, they did so without increasing the spread of COVID-19.

access_time Embargo lifts in 2 days
Embargo will expire: 18-May-2021 11:00 AM EDT Released to reporters: 12-May-2021 3:35 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 18-May-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Pandemic Has 'Severely Weakened Surgical Innovation Pipeline'
Released: 12-May-2021 3:15 PM EDT
Pandemic Has 'Severely Weakened Surgical Innovation Pipeline'
Johns Hopkins University Carey Business School

In a new study for the journal Surgical Innovation, Associate Professor Toby Gordon of the Johns Hopkins Carey Business School addresses the ways in which COVID-19 has slowed medical innovation.

Released: 12-May-2021 2:55 PM EDT
Mental health helplines need human-centered solutions
Cornell University

In India today, dozens of phone numbers are available for people who are having a severe mental health emergency. Oftentimes, however, callers experience difficulty in getting connected with someone who will listen to them; sometimes the phone will just ring and ring.

Newswise: Weizmann Institute Scientists Reveal the Triple Threat of Coronavirus
Released: 12-May-2021 2:40 PM EDT
Weizmann Institute Scientists Reveal the Triple Threat of Coronavirus
Weizmann Institute of Science

Scientists at the Weizmann Institute and the Israel Institute for Biological, Chemical and Environmental Sciences took a novel tack to investigating SARS-CoV-2’s powerful ability to infect, finding that the virus deploys an apparently unique three-pronged strategy to take over the cell’s protein-synthesis abilities. The work could help develop effective Covid-19 treatments.

Newswise: Rush Collaborates With Malcolm X College to Train COVID-19 Vaccine Ambassadors
Released: 12-May-2021 2:20 PM EDT
Rush Collaborates With Malcolm X College to Train COVID-19 Vaccine Ambassadors
Rush University Medical Center

Rush staff members collaborated with Malcom X College to provide content including video scenarios and conversation advice, for a new Vaccine Ambassador Course offered to the public.


Showing results

1120 of 5636

close
2.17447